Related references
Note: Only part of the references are listed.Memantine Improves Cognition and Reduces Alzheimer's-Like Neuropathology in Transgenic Mice
Hilda Martinez-Coria et al.
AMERICAN JOURNAL OF PATHOLOGY (2010)
A 25-week, open-label trial investigating rivastigmine transdermal patches with concomitant memantine in mild-to-moderate Alzheimer's disease: a post hoc analysis
Martin R. Farlow et al.
CURRENT MEDICAL RESEARCH AND OPINION (2010)
Aβ exacerbates the neuronal dysfunction caused by human tau expression in a Drosophila model of Alzheimer's disease
James Folwell et al.
EXPERIMENTAL NEUROLOGY (2010)
Safety and tolerability of rivastigmine capsule with memantine in patients with probable Alzheimer's disease: a 26-week, open-label, prospective trial (Study ENA713B US32)
Jason T. Olin et al.
INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY (2010)
Long-term effects of the concomitant use of memantine with cholinesterase inhibition in Alzheimer disease
O. L. Lopez et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2009)
Persistent treatment with cholinesterase inhibitors and/or memantine slows clinical progression of Alzheimer disease
Susan D Rountree et al.
Alzheimers Research & Therapy (2009)
Alzheimer's disease
Alistair Burns et al.
BMJ-BRITISH MEDICAL JOURNAL (2009)
Long-term course and effectiveness of combination therapy in Alzheimer disease
Alireza Atri et al.
ALZHEIMER DISEASE & ASSOCIATED DISORDERS (2008)
Memantine treatment in patients with mild to moderate Alzheimer's disease already receiving a cholinesterase inhibitor: A randomized, double-blind, placebo-controlled trial
Anton P. Porsteinsson et al.
CURRENT ALZHEIMER RESEARCH (2008)
Donepezil preserves cognition and global function in patients with severe Alzheimer disease
S. E. Black et al.
NEUROLOGY (2007)
100 years and counting: Prospects for defeating Alzheimer's disease
Erik D. Roberson et al.
SCIENCE (2006)
Memantine treatment in mild to moderate Alzheimer disease: A 24-week randomized, controlled trial
Elaine R. Peskind et al.
AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY (2006)
A responder analysis of memantine treatment in patients with Alzheimer disease maintained on donepezil
CH van Dyck et al.
AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY (2006)
Depression and risk for Alzheimer disease - Systematic review, meta-analysis, and metaregression analysis
RL Ownby et al.
ARCHIVES OF GENERAL PSYCHIATRY (2006)
Donepezil in patients with severe Alzheimer's disease:: double-blind, parallel-group, placebo-controlled study
B Winblad et al.
LANCET (2006)
A 24-week open-label extension study of memantine in moderate to severe Alzheimer disease
B Reisberg et al.
ARCHIVES OF NEUROLOGY (2006)
3-year study of donepezil therapy in Alzheimer's disease: Effects of early and continuous therapy
B. Winblad et al.
DEMENTIA AND GERIATRIC COGNITIVE DISORDERS (2006)
Steady-state pharmacokinetics of galantamine are not affected by addition of memantine in healthy subjects
CP Yao et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2005)
Memantine treatment in patients with moderate to severe Alzheimer disease already receiving donepezil - A randomized controlled trial
PN Tariot et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2004)
Efficacy of donepezil in early-stage Alzheimer disease - A randomized placebo-controlled trial
B Seltzer et al.
ARCHIVES OF NEUROLOGY (2004)
The NMDA receptor antagonist memantine as a symptomatological and neuroprotective treatment for Alzheimer's disease: preclinical evidence
W Danysz et al.
INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY (2003)
Alzheimer disease in the US population - Prevalence estimates using the 2000 census
LE Hebert et al.
ARCHIVES OF NEUROLOGY (2003)
Psychiatric symptoms vary with the severity of dementia in probable Alzheimer's disease
OL Lopez et al.
JOURNAL OF NEUROPSYCHIATRY AND CLINICAL NEUROSCIENCES (2003)
Memantine in moderate-to-severe Alzheimer's disease
B Reisberg et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Tolerability of memantine in combination with cholinesterase inhibitors in dementia therapy
S Hartmann et al.
INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY (2003)
A 24-week, randomized, double-blind study of donepezil in moderate to severe Alzheimer's disease
H Feldman et al.
NEUROLOGY (2001)
Efficacy and safety of galantamine in patients with mild to moderate Alzheimer's disease: multicentre randomised controlled trial
GK Wilcock et al.
BRITISH MEDICAL JOURNAL (2000)
Share Paper
